Global Information
회사소개 | 문의 | 비교리스트

세계의 체외진단 시장 : 유형, 기술, 용도, 최종사용자별 - 지역적 전망, 용도 잠재성, 시장 점유율, 예측(2019-2025년)

In-vitro Diagnostics Market Size By Type, By Technology, By Application By End-user, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

리서치사 Global Market Insights Inc.
발행일 2021년 11월 상품 코드 1039006
페이지 정보 영문 160 Pages
가격
US $ 5,150 ₩ 6,203,000 Unprintable PDF (Single User License)
US $ 7,150 ₩ 8,612,000 Printable PDF (Multi User License)
US $ 9,150 ₩ 11,021,000 Printable PDF (Enterprise User License)


세계의 체외진단 시장 : 유형, 기술, 용도, 최종사용자별 - 지역적 전망, 용도 잠재성, 시장 점유율, 예측(2019-2025년) In-vitro Diagnostics Market Size By Type, By Technology, By Application By End-user, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025
발행일 : 2021년 11월 페이지 정보 : 영문 160 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

체외진단 시장은 전 세계에서 만성질환 및 감염증이 증가하고 있는 것으로 인해 2027년까지 큰 성장이 전망됩니다.

제품 유형별로는 기기 부문이 약 4.5%의 CAGR로 확대하며, 큰 이익을 초래할 것으로 예측됩니다. 랩에서 체외진단용 기기의 수요가 높아지고 있으며, 이 부문의 성장이 전망됩니다. 또한 검사 유형별로는 분자진단 부문이 신종 코로나바이러스 감염증(COVID-19)의 영향으로 요구가 높아지고 있는 것으로 인해 예측 기간 중 약 5.6%의 CAGR로 성장할 것으로 예측되고 있습니다.

세계의 체외진단 시장을 조사했으며, 시장의 정의와 개요, COVID-19 및 기타 시장 영향요인 분석, 시장 규모의 추이·예측, 제품 유형·검사 유형·용도·최종사용자·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 조사 방법

제2장 개요

제3장 체외진단 산업 인사이트

  • 산업 세분화
  • 산업 상황
  • 산업에 대한 영향요인
    • 성장요인
    • 잠재적 리스크 & 과제
  • 성장의 가능성
  • COVID-19 : 영향 분석
  • Porter의 산업 분석
  • 경쟁 구도
  • PESTEL 분석

제4장 체외진단 시장 : 제품 유형별

  • 주요 동향
  • 시약·키트
  • 기기
    • 시장 규모·예측 : 지역별

제5장 체외진단 시장 : 검사 유형별

  • 주요 동향
  • 임상화학
  • 면역분석법/면역화학
  • 분자진단
  • 혈액검사
  • 요검사
  • 기타
    • 시장 규모·예측 : 지역별

제6장 체외진단 시장 : 용도별

  • 주요 동향
  • 종양
  • 감염증
  • 당뇨병
  • 심장병
  • 신장
  • 자가면역질환
  • 약물 검사/약물유전체학
  • 기타
    • 시장 규모·예측 : 지역별

제7장 체외진단 시장 : 최종사용자별

  • 주요 동향
  • 병원
  • 진단 검사 랩
  • 학술연구기관
  • 기타
    • 시장 규모·예측 : 지역별

제8장 체외진단 시장 : 지역별

  • 주요 동향
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동·아프리카

제9장 기업 개요

  • 전략 대시보드
  • Sysmex
  • F. Hoffmann-La Roche AG
  • Qiagen
  • Danaher
  • DiaSorin
  • Abbott
  • Bio-Rad Laboratories, Inc.
  • Ortho Clinical Diagnostics
  • Becton Dickinson and Company
  • Thermo Fisher Scientific
  • BioMerieux
  • Siemens Healthineers
KSA 21.12.16

Data Tables

  • TABLE 1 In vitro diagnostics market industry 360 degree synopsis, 2016 - 2027
  • TABLE 2 In vitro diagnostics market size, 2016-2027 (USD Million)
  • TABLE 3 In vitro diagnostics market size, By product type, 2016-2027 (USD Million)
  • TABLE 4 In vitro diagnostics market size, By test type, 2016-2027 (USD Million)
  • TABLE 5 In vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 6 In vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 7 In vitro diagnostics market size, by region, 2016-2027 (USD Million)
  • TABLE 8 Industry impact forces
  • TABLE 9 Reagents & kits market size, by region, 2016-2027 (USD Million)
  • TABLE 10 Instruments market size, by region, 2016-2027 (USD Million)
  • TABLE 11 Clinical chemistry market size, by region, 2016-2027 (USD Million)
  • TABLE 12 Immunoassay/immunochemistry market size, by region, 2016-2027 (USD Million)
  • TABLE 13 Molecular diagnostics market size, by region, 2016-2027 (USD Million)
  • TABLE 14 Hematology market size, by region, 2016-2027 (USD Million)
  • TABLE 15 Urinalysis market size, by region, 2016-2027 (USD Million)
  • TABLE 16 Others market size, by region, 2016-2027 (USD Million)
  • TABLE 17 Oncology market size, by region, 2016-2027 (USD Million)
  • TABLE 18 Infectious diseases market size, by region, 2016-2027 (USD Million)
  • TABLE 19 Diabetes market size, by region, 2016-2027 (USD Million)
  • TABLE 20 Cardiology market size, by region, 2016-2027 (USD Million)
  • TABLE 21 Nephrology market size, by region, 2016-2027 (USD Million)
  • TABLE 22 Autoimmune diseases market size, by region (USD Million)
  • TABLE 23 Drug testing/ pharmacogenomics market size, by region (USD Million)
  • TABLE 24 Others market size, by region (USD Million)
  • TABLE 25 North America in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 26 North America in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 27 North America in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 28 North America in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 29 North America in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 30 U.S. in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 31 U.S. in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 32 U.S. in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 33 U.S. in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 34 Canada in vitro diagnostics market size, By product type, 2016-2027 (USD Million)
  • TABLE 35 Canada in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 36 Canada in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 37 Canada in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 38 Europe in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 39 Europe in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 40 Europe in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 41 Europe in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 42 Europe in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 43 Germany in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 44 Germany in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 45 Germany in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 46 Germany in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 47 France in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 48 France in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 49 France in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 50 France in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 51 UK in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 52 UK in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 53 UK in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 54 UK in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 55 Italy in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 56 Italy in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 57 Italy in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 58 Italy in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 59 Spain in vitro diagnostics market size, By product type, 2016-2027 (USD Million)
  • TABLE 60 Spain in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 61 Spain in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 62 Spain in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 63 Asia Pacific in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 64 Asia Pacific in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 65 Asia Pacific in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 66 Asia Pacific in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 67 Asia Pacific in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 68 China in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 69 China in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 70 China in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 71 China in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 72 Japan in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 73 Japan in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 74 Japan in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 75 Japan in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 76 India in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 77 India in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 78 India in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 79 India in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 80 South Korea in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 81 South Korea in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 82 South Korea in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 83 South Korea in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 84 Australia in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 85 Australia in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 86 Australia in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 87 Australia in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 88 Latin America in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 89 Latin America in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 90 Latin America in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 91 Latin America in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 92 Latin America in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 93 Brazil in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 94 Brazil in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 95 Brazil in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 96 Brazil in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 97 Mexico in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 98 Mexico in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 99 Mexico in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 100 Mexico in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 101 MEA in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 102 MEA in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 103 MEA in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 104 MEA in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 105 MEA in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 106 Saudi Arabia in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 107 Saudi Arabia in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 108 Saudi Arabia in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 109 Saudi Arabia in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 110 UAE in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 111 UAE in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 112 UAE in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 113 UAE in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 114 South Africa in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 115 South Africa in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 116 South Africa in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 117 South Africa in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global in vitro diagnostics market size, 2016 - 2027 (USD Million)
  • FIG. 3 Growth potential analysis, by product type
  • FIG. 4 Growth potential analysis, by test type
  • FIG. 5 Growth potential analysis, by application
  • FIG. 6 Growth potential analysis, by end-user
  • FIG. 7 Porter's analysis
  • FIG. 8 Competitive matrix analysis, 2020
  • FIG. 9 PESTEL analysis
  • FIG. 10 Key segment trends, by product type
  • FIG. 11 Key segment trends, by test type
  • FIG. 12 Key segment trends, by application
  • FIG. 13 Key segment trends, by end-user
  • FIG. 14 Key regional trends, by region
  • FIG. 15 Strategy dashboard, 2020

The in vitro diagnostics market is anticipated to record considerable growth by 2027 owing to increasing incidences of chronic and infectious diseases across the globe.

In vitro diagnostic (IVD) tests are performed on samples collected from the human body, such as blood samples, swabs of mucus from the back of the throat or inside the nose from a fingerstick or vein. These tests can detect diseases or other disorders and help monitor a person's overall health to cure, treat, or prevent diseases. Recently, in vitro diagnostics have been an indispensable method of diagnosing and managing COVID-19 viral infections, which has fueled industry adoption during the pandemic.

Notably, industry players have been adopting profitable strategies to accommodate the mounting demand for IVD tests in view of the ongoing COVID-19 pandemic, thereby enhancing the global business scenario. For instance, in July 2021, DiaSorin S.p.A., a major diagnostics company, completed the acquisition of Luminex Corporation, a leading biotechnology company. The deal enabled DiaSorin to expand its business by leveraging Luminex's existing offerings and multiplexing technology.

The in vitro diagnostics market has been divided on the basis of end-user, product type, application, test type, and region. With respect to product type, the market has further been segregated into instruments and reagents & kits.

The instruments sub-segment is projected to amass considerable gains by 2027, expanding at a CAGR of about 4.5% over the review period. Escalating demand for in-vitro diagnostic instruments in laboratories is likely to foster segmental growth through the study timeline.

Based on test type, the in vitro diagnostics market has been categorized into urinalysis, clinical chemistry, hematology, immunoassay/immunochemistry, molecular diagnostics, and others. The molecular diagnostics sub-segment is slated to progress at around 5.6% CAGR over the forecast period owing to surging need for molecular diagnostics tests during the COVID-19 pandemic.

From the viewpoint of application, the market has been segmented into drug testing/ pharmacogenomics, oncology, autoimmune diseases, infectious diseases, nephrology, diabetes, cardiology, and others. The in vitro diagnostics market from the infectious diseases sub-segment surpassed a valuation of USD 18 billion in 2020 and is expected to witness robust expansion over 2021-2027. Rising prevalence of infectious diseases would create huge demand for IVD tests, which is estimated to augment segmental growth in the upcoming years.

In terms of end-user, the in vitro diagnostics market has been classified into academic & research institutes, hospitals, diagnostic laboratories, and others. In 2020, the hospitals sub-segment held around 40% market share and is speculated to showcase significant progress over the analysis timeline. Soaring availability of trained medical professionals and advanced diagnostic tools is set to propel segmental expansion.

From the regional perspective, the Latin America in vitro diagnostics market was valued at over USD 6 billion in 2020 and is poised to grow at a substantial pace through the assessment timeframe. The developing medical infrastructure, coupled with increasing demand for in vitro diagnostics in LATAM, is likely to drive regional market expansion.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 In vitro diagnostics industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Product type trends
    • 2.1.3 Test type trends
    • 2.1.4 Application trends
    • 2.1.5 End-user trends
    • 2.1.6 Regional trends

Chapter 3 In Vitro Diagnostics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of infectious and chronic diseases
      • 3.3.1.2 Growing adoption of personalized medicine
      • 3.3.1.3 Increasing adoption of point of care testing
      • 3.3.1.4 Surging number of pathology labs and services equipped with advanced diagnostics machine
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 High cost of diagnostic services
      • 3.3.2.2 Unfavorable reimbursement scenario
  • 3.4 Growth potential analysis
    • 3.4.1 By product type
    • 3.4.2 By test type
    • 3.4.3 By application
    • 3.4.4 By end-user
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2020
    • 3.7.1 Competitive matrix analysis, 2020
  • 3.8 PESTEL analysis

Chapter 4 In Vitro Diagnostics Market, By Product Type

  • 4.1 Key segment trends
  • 4.2 Reagents & kits
    • 4.2.1 Market size, by region, 2016 - 2027
  • 4.3 Instruments
    • 4.3.1 Market size, by region, 2016 - 2027

Chapter 5 In Vitro Diagnostics Market, By Test Type

  • 5.1 Key segment trends
  • 5.2 Clinical chemistry
    • 5.2.1 Market size, by region, 2016 - 2027
  • 5.3 Immunoassay/immunochemistry
    • 5.3.1 Market size, by region, 2016 - 2027
  • 5.4 Molecular diagnostics
    • 5.4.1 Market size, by region, 2016 - 2027
  • 5.5 Hematology
    • 5.5.1 Market size, by region, 2016 - 2027
  • 5.6 Urinalysis
    • 5.6.1 Market size, by region, 2016 - 2027
  • 5.7 Others
    • 5.7.1 Market size, by region, 2016 - 2027

Chapter 6 In Vitro Diagnostics Market, By Application

  • 6.1 Key segment trends
  • 6.2 Oncology
    • 6.2.1 Market size, by region, 2016 - 2027
  • 6.3 Infectious diseases
    • 6.3.1 Market size, by region, 2016 - 2027
  • 6.4 Diabetes
    • 6.4.1 Market size, by region, 2016 - 2027
  • 6.5 Cardiology
    • 6.5.1 Market size, by region, 2016 - 2027
  • 6.6 Nephrology
    • 6.6.1 Market size, by region, 2016 - 2027
  • 6.7 Autoimmune diseases
    • 6.7.1 Market size, by region, 2016 - 2027
  • 6.8 Drug testing/pharmacogenomics
    • 6.8.1 Market size, by region, 2016 - 2027
  • 6.9 Others
    • 6.9.1 Market size, by region, 2016 - 2027

Chapter 7 In Vitro Diagnostics Market, By End-user

  • 7.1 Key segment trends
  • 7.2 Hospitals
    • 7.2.1 Market size, by region, 2016 - 2027
  • 7.3 Diagnostic laboratories
    • 7.3.1 Market size, by region, 2016 - 2027
  • 7.4 Academic & research institutes
    • 7.4.1 Market size, by region, 2016 - 2027
  • 7.5 Others
    • 7.5.1 Market size, by region, 2016 - 2027

Chapter 8 In Vitro Diagnostics Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country 2016 - 2027
    • 8.2.2 Market size, by product type, 2016 - 2027
    • 8.2.3 Market size, by test type, 2016 - 2027
    • 8.2.4 Market size, by application, 2016 - 2027
    • 8.2.5 Market size, by end-user, 2016 - 2027
    • 8.2.6 U.S.
      • 8.2.6.1 Market size, By product type, 2016 - 2027
      • 8.2.6.2 Market size, By test type, 2016 - 2027
      • 8.2.6.3 Market size, by application, 2016 - 2027
      • 8.2.6.4 Market size, by end-user, 2016 - 2027
    • 8.2.7 Canada
      • 8.2.7.1 Market size, By product type, 2016 - 2027
      • 8.2.7.2 Market size, By test type, 2016 - 2027
      • 8.2.7.3 Market size, by application, 2016 - 2027
      • 8.2.7.4 Market size, by end-user, 2016 - 2027
  • 8.3 Europe
    • 8.3.1 Market size, by country 2016 - 2027
    • 8.3.2 Market size, by product type, 2016 - 2027
    • 8.3.3 Market size, by test type, 2016 - 2027
    • 8.3.4 Market size, by application, 2016 - 2027
    • 8.3.5 Market size, by end-user, 2016 - 2027
    • 8.3.6 Germany
      • 8.3.6.1 Market size, By product type, 2016 - 2027
      • 8.3.6.2 Market size, By test type, 2016 - 2027
      • 8.3.6.3 Market size, by application, 2016 - 2027
      • 8.3.6.4 Market size, by end-user, 2016 - 2027
    • 8.3.7 France
      • 8.3.7.1 Market size, By product type, 2016 - 2027
      • 8.3.7.2 Market size, By test type, 2016 - 2027
      • 8.3.7.3 Market size, by application, 2016 - 2027
      • 8.3.7.4 Market size, by end-user, 2016 - 2027
    • 8.3.8 UK
      • 8.3.8.1 Market size, By product type, 2016 - 2027
      • 8.3.8.2 Market size, By test type, 2016 - 2027
      • 8.3.8.3 Market size, by application, 2016 - 2027
      • 8.3.8.4 Market size, by end-user, 2016 - 2027
    • 8.3.9 Italy
      • 8.3.9.1 Market size, By product type, 2016 - 2027
      • 8.3.9.2 Market size, By test type, 2016 - 2027
      • 8.3.9.3 Market size, by application, 2016 - 2027
      • 8.3.9.4 Market size, by end-user, 2016 - 2027
    • 8.3.10 Spain
      • 8.3.10.1 Market size, By product type, 2016 - 2027
      • 8.3.10.2 Market size, By test type, 2016 - 2027
      • 8.3.10.3 Market size, by application, 2016 - 2027
      • 8.3.10.4 Market size, by end-user, 2016 - 2027
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country 2016 - 2027
    • 8.4.2 Market size, by product type, 2016 - 2027
    • 8.4.3 Market size, by test type, 2016 - 2027
    • 8.4.4 Market size, by application, 2016 - 2027
    • 8.4.5 Market size, by end-user, 2016 - 2027
    • 8.4.6 China
      • 8.4.6.1 Market size, By product type, 2016 - 2027
      • 8.4.6.2 Market size, By test type, 2016 - 2027
      • 8.4.6.3 Market size, by application, 2016 - 2027
      • 8.4.6.4 Market size, by end-user, 2016 - 2027
    • 8.4.7 Japan
      • 8.4.7.1 Market size, By product type, 2016 - 2027
      • 8.4.7.2 Market size, By test type, 2016 - 2027
      • 8.4.7.3 Market size, by application, 2016 - 2027
      • 8.4.7.4 Market size, by end-user, 2016 - 2027
    • 8.4.8 India
      • 8.4.8.1 Market size, By product type, 2016 - 2027
      • 8.4.8.2 Market size, By test type, 2016 - 2027
      • 8.4.8.3 Market size, by application, 2016 - 2027
      • 8.4.8.4 Market size, by end-user, 2016 - 2027
    • 8.4.9 South Korea
      • 8.4.9.1 Market size, By product type, 2016 - 2027
      • 8.4.9.2 Market size, By test type, 2016 - 2027
      • 8.4.9.3 Market size, by application, 2016 - 2027
      • 8.4.9.4 Market size, by end-user, 2016 - 2027
    • 8.4.10 Australia
      • 8.4.10.1 Market size, By product type, 2016 - 2027
      • 8.4.10.2 Market size, By test type, 2016 - 2027
      • 8.4.10.3 Market size, by application, 2016 - 2027
      • 8.4.10.4 Market size, by end-user, 2016 - 2027
  • 8.5 Latin America
    • 8.5.1 Market size, by country 2016 - 2027
    • 8.5.2 Market size, By product type, 2016 - 2027
    • 8.5.3 Market size, By test type, 2016 - 2027
    • 8.5.4 Market size, by application, 2016 - 2027
    • 8.5.5 Market size, by end-user, 2016 - 2027
    • 8.5.6 Brazil
      • 8.5.6.1 Market size, By product type, 2016 - 2027
      • 8.5.6.2 Market size, By test type, 2016 - 2027
      • 8.5.6.3 Market size, by application, 2016 - 2027
      • 8.5.6.4 Market size, by end-user, 2016 - 2027
    • 8.5.7 Mexico
      • 8.5.7.1 Market size, By product type, 2016 - 2027
      • 8.5.7.2 Market size, By test type, 2016 - 2027
      • 8.5.7.3 Market size, by application, 2016 - 2027
      • 8.5.7.4 Market size, by end-user, 2016 - 2027
  • 8.6 Middle East and Africa
    • 8.6.1 Market size, by country 2016 - 2027
    • 8.6.2 Market size, By product, 2016 - 2027
    • 8.6.3 Market size, by application, 2016 - 2027
    • 8.6.4 Market size, by end-user, 2016 - 2027
    • 8.6.5 Saudi Arabia
      • 8.6.5.1 Market size, By product type, 2016 - 2027
      • 8.6.5.2 Market size, By test type, 2016 - 2027
      • 8.6.5.3 Market size, by application, 2016 - 2027
      • 8.6.5.4 Market size, by end-user, 2016 - 2027
    • 8.6.6 UAE
      • 8.6.6.1 Market size, By product type, 2016 - 2027
      • 8.6.6.2 Market size, By test type, 2016 - 2027
      • 8.6.6.3 Market size, by application, 2016 - 2027
      • 8.6.6.4 Market size, by end-user, 2016 - 2027
    • 8.6.7 South Africa
      • 8.6.7.1 Market size, by product type, 2016 - 2027
      • 8.6.7.2 Market size, by test type, 2016 - 2027
      • 8.6.7.3 Market size, by application, 2016 - 2027
      • 8.6.7.4 Market size, by end-user, 2016 - 2027

Chapter 9 Company Profiles

  • 9.1 Strategy dashboard, 2020
  • 9.2 Sysmex
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 F. Hoffmann-La Roche AG
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 Qiagen
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Danaher
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 DiaSorin
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 Abbott
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 Bio-Rad Laboratories, Inc.
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 Ortho Clinical Diagnostics
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
  • 9.10 Becton Dickinson and Company
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 Strategic outlook
    • 9.10.5 SWOT analysis
  • 9.11 Thermo Fisher Scientific
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis
  • 9.12 BioMerieux
    • 9.12.1 Business overview
    • 9.12.2 Financial data
    • 9.12.3 Product landscape
    • 9.12.4 Strategic outlook
    • 9.12.5 SWOT analysis
  • 9.13 Siemens Healthineers
    • 9.13.1 Business overview
    • 9.13.2 Financial data
    • 9.13.3 Product landscape
    • 9.13.4 Strategic outlook
    • 9.13.5 SWOT analysis
Back to Top
전화 문의
F A Q